JULIE LITTLEJOHN: Open Payments
NPI 1457960528 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 28 payments from 16 companies in 2025. Trend: 2023 $559 · 2024 $1,791 · 2025 $876
Food & beverage: $777Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $159 |
| Daiichi Sankyo Inc. | 4 | $108 |
| Incyte Corporation | 1 | $99 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| PFIZER INC. | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Eisai Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Rigel Pharmaceuticals, Inc. | 1 | $31 |
Products named: RYBREVANT, Enhertu, KEYTRUDA, Lenvima, TALVEY, CALQUENCE, ICLUSIG, TAVALISSE.
Industry payments across VA — which companies pay providers there.
